New drug against HIV may revolutionize treatment in the elderly
A new daily single-dose pill for HIV treatment, BIC/LEN, has shown promise in clinical trials, simplifying the lives of long-term HIV patients.
Use of polylaminin is monitored in real time by society: 'Like a Big Brother', says researcher
Research on polylaminin, a substance being studied as a possible treatment for spinal cord injuries, is closely monitored by society, according to lead researcher Tatiana Sampaio.
South Africa: "Ethics, Trust, and the Future of Pediatric HIV Cure"
A recent webinar addressed the ethical and scientific considerations in pediatric HIV cure research, highlighting the role of people living with HIV in this field.
What do we know about Mazdutide, the medication with which you can lose up to 20 kilograms in a year?
Mazdutide, a weight-loss medication, shows significant weight loss results in a Chinese study, with participants losing an average of nearly 19% of their body weight over 48 weeks.
The first clinical trial to 'reprogram' human aging is launched
The first human clinical trial aimed at reversing aging processes has begun, announced by Dr. David Sinclair at the World Government Summit.
Research on new medications, such as polylaminin, must follow strict international rules
The development of new medications, including polylaminin, requires adherence to strict international guidelines, particularly in clinical trials that involve control groups to assess efficacy and safety.
Polylaminin is promising, but must overcome clinical trials
Polylaminin shows promise as a potential treatment for severe spinal injuries but faces significant challenges in clinical testing.
The increase in clinical trials in the EU will bring an additional 4 billion euros to healthcare systems
The European Commission and related organizations are striving to attract more clinical trials, which could generate additional funding and job creation in the healthcare sector.
Don't treat polylaminin as if it were the national team
The article discusses the recent hype surrounding polylaminin, a substance believed to regenerate spinal cord injuries, and its political implications in Brazil.
Neurologists alert to lack of evidence on the action of poly-L-lysine in spinal cord injury
Brazilian neurologists warn about insufficient scientific evidence supporting the use of poly-L-lysine for treating spinal cord injuries in humans.
Wegovy and Ozempic owner dealt blow as next-gen weight-loss drug is branded ‘obsolete’
Novo Nordisk's new weight-loss drug, CagriSema, has been deemed 'obsolete' after disappointing clinical trials, leading to a significant drop in the company's shares.
Problem with obesity drugs: patients lose too much weight, get scared, and stop taking them
A new obesity drug trial reveals significant weight loss but raises concerns as patients abandon the study due to fears of losing too much weight.
Alzheimer: Are Alzheimer drugs really not useful?
Experts from the Joint Federal Committee of Germany find no additional benefit for the Alzheimer drug Lecanemab compared to existing therapies.
Discover business models competing in the psychedelic market
Companies Cybin/Helus from Canada and Compass Pathways from the UK have reported promising data about psychedelics for depression.
Hope Against Triple Negative Breast Cancer: Experimental Vaccine Shows Positive Results
An experimental mRNA vaccine shows promising outcomes in a small trial for triple-negative breast cancer patients.
Let the death row inmates have hope.
A 62-year-old ALS patient in Norway describes her struggle to access life-prolonging medication after being denied participation in clinical trials and treatment options, highlighting the paradox of medical regulations.
"Hold on, this is what we were waiting for": Are the new clinical trials against baldness the dreamed revolution?
The clinical trials for PP405, a drug financed by Google aimed at treating androgenetic alopecia, have generated excitement among many men facing hair loss, though experts caution it is not yet a replacement for hair transplants.
'Tipping point' reached in creation of brain chips that can read thoughts
Researchers have reached a significant milestone in creating brain chips that can read thoughts, aiming to assist people with paralysis, with clinical trials set to begin soon.
Nipah virus vaccine from Japan set to begin clinical trials in April, promising prevention of the disease
A Japanese-developed Nipah virus vaccine is scheduled to begin clinical trials in Belgium in April, aiming to prevent the disease.
Moderna claims that the US refuses to review the mRNA-based flu vaccine
Moderna asserts that the US FDA has declined to review its mRNA-based flu vaccine due to concerns over inadequate clinical trials and lack of proper comparison with existing products.
Great Expectations for Vaccine Against Advanced Lung Cancer: What the Director of St. Savvas Oncology Says
The director of St. Savvas Oncology, Alexandros Ardavani, expresses optimism regarding an mRNA therapeutic vaccine currently undergoing trials for advanced lung cancer.
Scientists have a new idea for fighting depression. This method is a chance for many patients
Researchers propose a new approach to combat depression, particularly focusing on a subtype linked to immune system dysregulation, supported by recent clinical trial findings on anti-inflammatory treatments.
How the drugs that will revolutionize obesity treatment work
Semaglutide by Novo Nordisk is the first drug approved for obesity treatment that achieves weight loss comparable to bariatric surgery, while Eli Lilly's tirzepatide is expected to gain approval soon after showing efficacy and safety in clinical trials.
Day of Fight Against Cancer. Scientist: It is worth paying attention to what precedes clinical trials
The article discusses the increasing cancer challenges, focusing on the importance of understanding drug effectiveness before clinical trials, as cancer remains a leading cause of death in Poland.
A Spaniard leads a breakthrough that could accelerate the HIV vaccine
A Spanish scientist has made significant progress that could lead to accelerated development of an HIV vaccine, pending funding for human trials.
Mariano Barbacid against pancreatic cancer: the researcher and his team ask for help to start clinical trials
Mariano Barbacid and his team have developed a groundbreaking therapy that completely cured the most common form of pancreatic cancer in mice and are seeking assistance to begin clinical trials.
The new trends and the big gaps in clinical trials
Experts believe that the new Joint Ministerial Decision on clinical trials leaves significant gaps, which could hinder Greece's competitiveness in the international arena.
Podcast: the Brazilian experimental drug that may be hope for spinal cord injuries
The podcast discusses polylaminin, an experimental drug showing promise in restoring movement for patients with spinal cord injuries, highlighted by the case of a Brazilian influencer who regained arm movement after treatment.
A vaccine to prevent colon cancer shows promising results
A preventive vaccine, Nous-209, shows promising results in initial trials with patients at a significantly higher risk of developing tumors.
What health benefits do elderberry berries have?
Elderberry is known as a natural remedy for colds and flu, with some compounds possibly aiding blood pressure regulation, but current evidence is limited to laboratory and animal studies rather than human clinical trials, and raw elderberries can be toxic if not cooked properly.
From manned missions to the Moon to the treatment of rare diseases: The scientific milestones expected in 2026
The article discusses significant scientific milestones anticipated for 2026, including a manned Moon mission after 54 years, groundbreaking clinical trials, space missions, and major drilling projects.